OTCPK:CLVLF (Australia)  
Clinuvel Pharmaceuticals Ltd logo

Clinuvel Pharmaceuticals Ltd

$ 11.50 0 (0%) 09:40 AM EST
P/E:
46.10
P/B:
7.31
Market Cap:
$ 597.55M
Enterprise V:
$ 519.28M
Volume:
100.00
Avg Vol (2M):
2.81K
Also Trade In:
Volume:
100.00
Market Cap $:
597.55M
PE Ratio:
46.10
Avg Vol (2-Month):
2.81K
Enterprise Value $:
519.28M
PB Ratio:
7.31
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Clinuvel Pharmaceuticals Ltd is an Australia-based biopharmaceutical company. It is engaged in developing drugs for the treatment of genetic and vascular disorders. Its principal compound, SCENESSE is a drug for erythropoietic protoporphyria. Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to harmful UV radiation and at repigmentation of the skin due to several depigmentation disorders. Geographically, it derives a majority of its revenue from Europe and the USA.

Financials

CLVLF's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CLVLF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 46.495
EPS (TTM) ($) 0.285
Beta 1.06
Volatility % 49.74
14-Day RSI 34.17
14-Day ATR ($) 0.304533
20-Day SMA ($) 13.16096
12-1 Month Momentum % -56.21
52-Week Range ($) 9.5 - 30.4
Shares Outstanding (Mil) 49.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clinuvel Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data

Clinuvel Pharmaceuticals Ltd Analysis

Share your research

Headlines

See More
No news.